Bevacizumab decreases vestibular schwannomas growth rate in children and teenagers with neurofibromatosis type 2.
Hochart A, Gaillard V, Baroncini M, André N, Vannier JP, Vinchon M, Dubrulle F, Lejeune JP, Vincent C, Nève V, Sudour Bonnange H, Bonne NX, Leblond P.
Hochart A, et al. Among authors: bonne nx.
J Neurooncol. 2015 Sep;124(2):229-36. doi: 10.1007/s11060-015-1828-8. Epub 2015 May 29.
J Neurooncol. 2015.
PMID: 26022982